Correction: HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients (Antiviral Therapy (2016) DOI: 10.3851/IMP3055)

Timothy N.A. Archampong; Ceejay L. Boyce; Margaret Lartey; Kwamena W. Sagoe; Adjoa Obo-Akwa; Ernest Kenu; Jason T. Blackard; Awewura Kwara

doi:10.3851/IMP3067

Correction: HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients (Antiviral Therapy (2016) DOI: 10.3851/IMP3055)

Timothy N.A. Archampong
, Ceejay L. Boyce
, Margaret Lartey
, Kwamena W. Sagoe
, Adjoa Obo-Akwa
, Ernest Kenu
, Jason T. Blackard
, Awewura Kwara

Department of Medical Microbiology

University of Ghana
Korle Bu Teaching Hospital
University of Cincinnati
Brown University
Miriam Hospital

Research output: Contribution to journal › Comment/debate

Abstract

The publisher would like to report an error that appeared in a recently published article [1]. In the abstract the sentence 'Of these 63 patients, 27 (42.9%) were ART37 experienced, and 58 (92.1%) had HBV genotype E.' should appear as 'Of these 63 patients, 27 (42.9%) were ART-experienced and 58 (92.1%) had HBV genotype E'. The publisher apologizes for this error.

Original language	English
Pages (from-to)	91
Number of pages	1
Journal	Antiviral Therapy
Volume	22
Issue number	1
DOIs	https://doi.org/10.3851/IMP3067
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.3851/IMP3067

Cite this

Archampong, T. N. A., Boyce, C. L., Lartey, M., Sagoe, K. W., Obo-Akwa, A., Kenu, E., Blackard, J. T., & Kwara, A. (2017). Correction: HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients (Antiviral Therapy (2016) DOI: 10.3851/IMP3055). Antiviral Therapy, 22(1), 91. https://doi.org/10.3851/IMP3067

@article{d3783939cb884785b4c5db056d2b4bca,

title = "Correction: HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients (Antiviral Therapy (2016) DOI: 10.3851/IMP3055)",

abstract = "The publisher would like to report an error that appeared in a recently published article [1]. In the abstract the sentence 'Of these 63 patients, 27 (42.9\%) were ART37 experienced, and 58 (92.1\%) had HBV genotype E.' should appear as 'Of these 63 patients, 27 (42.9\%) were ART-experienced and 58 (92.1\%) had HBV genotype E'. The publisher apologizes for this error.",

author = "Archampong, \{Timothy N.A.\} and Boyce, \{Ceejay L.\} and Margaret Lartey and Sagoe, \{Kwamena W.\} and Adjoa Obo-Akwa and Ernest Kenu and Blackard, \{Jason T.\} and Awewura Kwara",

note = "Publisher Copyright: {\textcopyright}2017 International Medical Press.",

year = "2017",

doi = "10.3851/IMP3067",

language = "English",

volume = "22",

pages = "91",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "Sage Publications",

number = "1",

}

Archampong, TNA, Boyce, CL, Lartey, M, Sagoe, KW, Obo-Akwa, A, Kenu, E, Blackard, JT & Kwara, A 2017, 'Correction: HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients (Antiviral Therapy (2016) DOI: 10.3851/IMP3055)', Antiviral Therapy, vol. 22, no. 1, pp. 91. https://doi.org/10.3851/IMP3067

Correction: HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients (Antiviral Therapy (2016) DOI: 10.3851/IMP3055). / Archampong, Timothy N.A.; Boyce, Ceejay L.; Lartey, Margaret et al.
In: Antiviral Therapy, Vol. 22, No. 1, 2017, p. 91.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction

T2 - HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients (Antiviral Therapy (2016) DOI: 10.3851/IMP3055)

AU - Archampong, Timothy N.A.

AU - Boyce, Ceejay L.

AU - Lartey, Margaret

AU - Sagoe, Kwamena W.

AU - Obo-Akwa, Adjoa

AU - Kenu, Ernest

AU - Blackard, Jason T.

AU - Kwara, Awewura

PY - 2017

Y1 - 2017

N2 - The publisher would like to report an error that appeared in a recently published article [1]. In the abstract the sentence 'Of these 63 patients, 27 (42.9%) were ART37 experienced, and 58 (92.1%) had HBV genotype E.' should appear as 'Of these 63 patients, 27 (42.9%) were ART-experienced and 58 (92.1%) had HBV genotype E'. The publisher apologizes for this error.

AB - The publisher would like to report an error that appeared in a recently published article [1]. In the abstract the sentence 'Of these 63 patients, 27 (42.9%) were ART37 experienced, and 58 (92.1%) had HBV genotype E.' should appear as 'Of these 63 patients, 27 (42.9%) were ART-experienced and 58 (92.1%) had HBV genotype E'. The publisher apologizes for this error.

UR - https://www.scopus.com/pages/publications/85015839408

U2 - 10.3851/IMP3067

DO - 10.3851/IMP3067

M3 - Comment/debate

AN - SCOPUS:85015839408

SN - 1359-6535

VL - 22

SP - 91

JO - Antiviral Therapy

JF - Antiviral Therapy

IS - 1

ER -

Correction: HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients (Antiviral Therapy (2016) DOI: 10.3851/IMP3055)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this